Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis

By afschroeder • June 25, 2025

Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T. Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2025 Jun 23;11(3):00738-2024. doi: 10.1183/23120541.00738-2024. PMID: 40551789; PMCID: PMC12183712.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023

GBD 2023 Myocarditis Collaborators. Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023. J Am Coll Cardiol. 2026 Oct 13;88(15):1730-1760. doi: 10.1016/j.jacc.2026.07.039. Epub[...]

Moyamoya disease presenting as galactorrhea

Noveir SD, Agrawal N. Moyamoya disease presenting as galactorrhea. JCEM Case Rep. 2026 Oct 13;4(11):luag296. doi: 10.1210/jcemcr/luag296. PMID: 42871260; PMCID: PMC13658269.

Muscle-lung crosstalk in COPD: how exercise training modulates protein metabolism and inflammation in experimental COPD models

Abbasi A, Vieira RP, Degobbi T Q S Lopes F. Muscle-lung crosstalk in COPD: how exercise training modulates protein metabolism and inflammation in experimental COPD[...]